Matrix metalloproteinases in human melanoma

Journal of Investigative Dermatology

Volumn 115, Issue 3, 2000, Pages 337-344

  Hofmann, Uta B ^a   Westphal, Johan R ^b   Van Muijen, Goos N P ^a   Ruiter, Dirk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adhesion molecules; Matrix metalloproteinases; Melanoma; Tissue inhibitor of matrix metalloproteinases; Tumor progression

Indexed keywords

CELL ADHESION MOLECULE; COLLAGENASE; COLLAGENASE 3; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL SURFACE; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

EID: 0033828585     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00068.x     Document Type: Review

References (93)

1. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
2. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas
3. Tumor cell invasion inhibited by TIMP-2
4. Molecular biology of cutaneous malignant melanoma
5. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells
6. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
7. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases
8. Matrix metalloproteinases: A review
9. Thickness cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
10. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
11. Matrix metalloproteinase inhibition: A review of antitumour activity
12. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study
13. Changing views of the role of matrix metalloproteinases in metastasis
14. The histogenesis and biologic behavior of primary human malignant melanomas of the skin
15. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
16. Matrix metalloproteinases and the development of cancer
17. Matrix metalloproteinases in tumour invasion and metastasis
18. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
19. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1
20. Proteases in cutaneous melanoma
21. Batimastat, a synthetic inhibitor of matrix metalloproteinases potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts
22. Interaction of 92-kDa type collagenase with the tissue inhibitor of metalloproteinases prevents dimerization IV, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin
23. Tissue inhibitors of metalloproteinases: Structure regulation and biological functions
24. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
25. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
26. Tissue inhibitors of matrix metalloproteinases (TIMP) in invasion and proliferation
27. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
28. Biology of tumor progression in human melanocytes
29. Stromal cell expression of components of matrix-degrading protease systems in human cancer
30. Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
31. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type matrix metalloproteinase 1 (MT1-MMP) correlate with melanoma progression
32. 3 correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells invitro and in vivo
33. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
34. Experimental metastasis is suppressed in MMP-9-deficient mice
35. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase
36. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1
37. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells
38. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo
39. Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts
40. Matrix metalloproteinases and metastasis
41. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
42. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
43. Regulation of membrane-type-1 matrix metalloproteinase (MT1-MMP) activity by its cytoplasmic domain
44. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
45. Contributions of tumor and stromal matrix metalloproteinases to tumor progression invasion and metastasis
46. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells
47. 'Proteolytic switching': Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
48. Cytokine regulation of metalloproteinase gene expression
49. Melanoma-mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase- dependent proteolytic pathways
50. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
51. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis
52. Proteolysis and cell migration: Creating a path?
53. Activation mechanisms of matrix metalloproteinases
54. Cell surface activation of progelatinase A (proMMP-2) and cell migration
55. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
56. TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin
57. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
58. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
59. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas
60. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin
61. Membrane-type metalloproteinases in tumor invasion
62. Stromal expression of 72 kda type collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
63. Localization of messenger RNA for Mr 72,000 and 92,000 type IV coliagenases in human skin cancers by in situ hybridization
64. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
65. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
66. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
67. A matrix metalloproteinase expressed on the surface of invasive tumour cells
68. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)
69. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells
70. Role of the alpha v beta 3 integrin in human melanoma cell invasion
71. The 72 kDa IV type collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion
72. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
73. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
74. Tumor cell interactions with the extracellular matrix during invasion and metastasis
75. Marimastat (BB 2516): Current status of development
76. Mechanism of cell surface activation of 72-kDa type collagenase. Isolation of the activated form of the membrane metalloprotease
77. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
78. Stromelysin-3 (ST-3): Immunohistochemical characterization of the matrix metalloproteinase (MMP) -11 in benign and malignant skin tumours and other skin disorders
79. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas
80. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
81. Prognostic value of MMP-2 immunoreactive protein (72kD type collagenase) in primary skin melanoma
82. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
83. Plasminogen activators, their inhibitors and urokinase receptor emerge in late stages of melanocytic tumor progression
84. The plasminogen activation system in melanoma cell lines and in melanocytic lesions
85. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma
86. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
87. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models
88. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat in a human colorectal cancer ascites model
89. Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: Relationship with levels of circulating CEA
90. Regulation of matrix metalloproteinase expression in tumor invasion
91. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
92. Collagenase immunolocalization studies of cutaneous secondary melanomas
93. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated minor invasion